publication date: Apr. 3, 2015

Cantley, Adams-Campbell to Deliver Lectures At AACR Annual Meeting in Philadelphia


LEWIS CANTLEY was honored with the ninth annual Princess Takamatsu Memorial Lectureship, to be delivered at the American Association for Cancer Research annual meeting in Philadelphia, April 18-22.

Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center, the Margaret and Herman Sokol professor in oncology research, and a professor of cancer biology in medicine at Weill Cornell Medical College, is being recognized for his contributions to the field of growth factor and oncogene signaling.

This lectureship honors his discovery of the phosphoinositide 3-kinase enzyme and his subsequent work delineating the PI3K signaling pathway. His research has shown that this pathway is commonly activated in cancer and has paved the way for the development of therapeutics aimed at inhibiting PI3K signaling.

He will present his lecture, “Targeting PI3K for Cancer Therapy,” Monday, April 20. Cantley is also chair of this year’s AACR Annual Meeting Scientific Program Committee.

The AACR Princess Takamatsu Memorial Lectureship is presented to a scientist whose novel and significant work had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of the princess to multinational collaborations. Her Imperial Highness Princess Kikuko Takamatsu was instrumental in promoting cancer research and encouraging cancer scientists. She became a champion for these causes following her mother’s death from bowel cancer in 1933 at the young age of 43.

Cantley is credited with a key role in elucidating the molecular components of several signaling networks that are fundamental to cell growth. His most significant contribution to cancer research has been his 1988 discovery of … Continue reading 41-13 Cantley, Adams-Campbell to Deliver Lectures At AACR Annual Meeting in Philadelphia

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.